Logo

American Heart Association

  2
  0


Final ID: Su4129

Identifying Sex-Specific Risk Profiles in Patients with Non-ischemic Cardiomyopathy: A Cardiac MRI Study

Abstract Body (Do not enter title and authors here):
Introduction: Sex-based differences in cardiac remodeling have been identified in patients with non-ischemic cardiomyopathy (NICM). There is conflicting data regarding sex differences in outcomes in these patients, which may be related to heterogenous risk profiles. We sought to assess sex specific modulators of risk, based on assessment with cardiac magnetic resonance (CMR) imaging.
Methods: We conducted a retrospective analysis of patients with NICM who underwent cardiac MRI between 2001 and 2017. The primary endpoint was a composite outcome of death, heart transplant, heart failure admission and LVAD. The study cohort was divided into male and female subgroups, and univariate cox regression was performed to evaluate differential risk factor profiles.
Results: We evaluated 634 patients: 255 females (40.3%) and 377 males (59.7%), see fig 1(A) for baseline demographic characteristics and CMR parameters. On Kaplan-Meier analysis, outcomes were similar in males and females (p=0.662). On Cox regression, hypertension (HR: 1.91 [CI 1.22-3.0]; p=0.005), diabetes (HR: 3.17 [CI 1.94-5.18]; p<0.001) and LGE (HR: 1.11 [CI 1.01-1.21]; p=0.030) were associated with adverse outcomes in females only. While LA ejection fraction (LAEF) (HR 0.87 [CI 0.82 - 0.93]; p<0.001) and eGFR (HR 0.88 [CI 0.80-0.95]; p=0.002) were associated with adverse outcomes in males only, see fig 2, left atrial volume index (LAVi) and LA reservoir strain were associated with the composite outcome in both males and females.
Conclusion: Despite similar outcomes in men and women with NICM, we found significant differences in the modulators of risk and cardiac structure and function based on sex. Notably, LGE and diabetes were unique predictors of risk in females, despite similar prevalence. On the other hand, LAEF and renal function were uniquely predictive of adverse outcomes in males. Further work is needed to elucidate sex specific biologic mechanisms of risk to better characterize sex specific phenotypes.
  • Rizkallah, Diane  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Nguyen, Christopher  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Wang, Xiaofeng  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Kwon, Deborah  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Korkerdsup, Theerawat  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Ammoury, Carl  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Bodi, Kashyap  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Wu, Yanjun  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Wang, Tom Kai Ming  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Calcagno, Tess  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Tang, Wai Hong  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Chen, David  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Author Disclosures:
    Diane Rizkallah: DO NOT have relevant financial relationships | Christopher Nguyen: DO NOT have relevant financial relationships | Xiaofeng Wang: DO NOT have relevant financial relationships | Deborah Kwon: No Answer | Theerawat Korkerdsup: DO NOT have relevant financial relationships | Carl Ammoury: DO NOT have relevant financial relationships | Kashyap Bodi: DO NOT have relevant financial relationships | Yanjun Wu: DO NOT have relevant financial relationships | Tom Kai Ming Wang: DO NOT have relevant financial relationships | Tess Calcagno: DO NOT have relevant financial relationships | Wai Hong Tang: DO have relevant financial relationships ; Consultant:Sequana Medical:Active (exists now) ; Other (please indicate in the box next to the company name):Belvoir Media Group (honoraria):Active (exists now) ; Other (please indicate in the box next to the company name):American Board of Internal Medicine (exam approval committee):Past (completed) ; Consultant:BioCardia Inc:Active (exists now) ; Consultant:Salubris Biotherapeutics:Active (exists now) ; Consultant:Alexion Pharmaceuticals:Active (exists now) ; Consultant:Alleviant Medical:Active (exists now) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Intellia Therapeutics:Active (exists now) ; Consultant:CardicTec Biosciences:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:WhilteSwell:Active (exists now) ; Consultant:Zehna Therapeutics:Active (exists now) ; Consultant:Genomics plc:Active (exists now) ; Consultant:Cardiol Therapeutics:Active (exists now) | David Chen: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

MRI Multiparametric Tools for Deciphering Controversial Diagnostic Challenges

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts from these authors:
Impact of the Addition of Cardiac MRI Features and Sex Interactions with a Validated Clinical Risk Score to Improve Discrimination of Risk

Rizkallah Diane, Chen David, Nguyen Christopher, Tang Wai Hong, Kwon Deborah, Ammoury Carl, Bodi Kashyap, Korkerdsup Theerawat, Obuchowski Nancy, Wang Tom Kai Ming, Poppe Katrina, Doughty Robert, Calcagno Tess

Advanced Cardiac MRI Parameters Phenomapping to Predict Outcomes in Patients with Nonischemic Cardiomyopathy

Ammoury Carl, Tang Wai Hong, Wang Xiaofeng, Kwon Deborah, Wu Yanjun, Korkerdsup Theerawat, Wang Tom Kai Ming, Rizkallah Diane, Bodi Kashyap, Calcagno Tess, Chen David, Nguyen Christopher

You have to be authorized to contact abstract author. Please, Login
Not Available